Edwards Lifesciences Corporation (EW) Stock Analysis

Edwards Lifesciences Corporation (EW) Stock Analysis — AI Research | MarketCI

EW

Market Closed

Edwards Lifesciences Corporation

NYSEHealthcare Medical - Devices

15.80K employees

CEO: Bernard J. Zovighian

Founded: 2000

$87.36

+$0.00(+NaN%)

Market Cap

50.30B

Beta

0.87

52W Range

N/A

Dividend Yield

0.00%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

EW Price Chart

Historical price performance

Loading MCI price data...

MarketCI Investment Signals

AI-synthesized investment signal for EW built from valuation, fundamentals, sentiment, and risk models

Investment Signal

Hold

Pass %

57.14%

Score

4/7

Fair Value Estimate

Cash flow analysis • Multiple methods

$63.59

AI Price Target

Machine learning • Price prediction

$87.34

Market Sentiment

News & social media analysis

0.05

Value Investor Price

Classic value analysis

$16.24

Financial Health

Bankruptcy risk assessment

12.00

Quality Score

Financial strength rating

6.00

AI Investment Grade

Deep analysis of filings & news

78.00

Key Investment Highlights

Important factors affecting EW investment thesis

Due Diligence Analysis

Investment criteria assessment and scoring

Overall Assessment

63.41% Good

Conditions Met

26.00/41.00

Due Diligence Score

63.41%

Due Diligence Conditions

Investment analysis conditions and results


	Fail
	Fail
	Fail
	Fail
	Fail
	Pass

Showing 1 to 6 of 46 conditions